The Veterinary CRO and CDMO market size was valued at USD 10.7 Billion in 2022 and is projected to reach USD 19.4 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. The market growth is driven by increasing demand for veterinary medicines, vaccines, and other animal health products. The rising need for outsourcing drug development and manufacturing services in the veterinary industry is also expected to propel market growth. Furthermore, the increasing focus on pet care, livestock management, and the growing importance of animal health are contributing to the demand for veterinary contract research and manufacturing services.
As of 2022, the market showed significant expansion potential in both developed and emerging markets. The global rise in zoonotic diseases, as well as the push for more innovative and tailored veterinary treatments, is likely to boost the role of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). This trend is anticipated to create more business opportunities for service providers in the veterinary healthcare sector. The market is poised to continue expanding with increased investments in R&D, manufacturing, and regulatory compliance, contributing to a favorable long-term growth trajectory.
Download Full PDF Sample Copy of Market Report @
Veterinary CRO and CDMO Market Research Sample Report
The Veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is witnessing a steady expansion due to increasing demand for veterinary drugs, animal health solutions, and research-based services. The Veterinary CRO segment primarily focuses on providing services related to research and development (R&D), clinical trials, regulatory support, and testing. These organizations assist veterinary pharmaceutical companies and biotechnology firms by accelerating the time-to-market for new products, providing expertise in pre-clinical and clinical phases, and ensuring compliance with regulations. Veterinary CROs serve as a bridge between the initial concept phase and commercialization, addressing the growing need for innovation and effective treatment solutions in veterinary medicine.
As the veterinary pharmaceutical industry grows, so does the need for outsourced research and development services. Veterinary CROs play an essential role in supporting companies with their specialized skills in conducting trials, regulatory filings, and data management, all critical for the success of new treatments. These organizations often collaborate with veterinary pharmaceutical companies to ensure products meet the regulatory requirements and market expectations across different regions. The increasing demand for veterinary medications to treat a variety of animal diseases and conditions, along with the trend toward personalized veterinary medicine, is expected to boost the Veterinary CRO market's growth in the coming years.
The Veterinary Contract Development and Manufacturing Organization (CDMO) market is driven by the growing need for efficient and scalable manufacturing solutions for veterinary medicines and medical devices. Veterinary CDMOs focus on the end-to-end development and production of pharmaceutical products, including formulation development, clinical manufacturing, commercial production, and packaging. This market is experiencing growth as companies seek to outsource manufacturing processes to experts with specialized equipment and knowledge to ensure high-quality, cost-effective production of animal health products. Veterinary CDMOs play an essential role in enabling companies to scale production quickly while maintaining stringent regulatory standards for product safety and quality.
In the context of veterinary pharmaceutical companies, veterinary CDMOs are responsible for producing a wide range of products, such as vaccines, antibiotics, and anti-inflammatory drugs, which are used for treating animals in both companion and livestock sectors. The increasing demand for veterinary medicines, driven by the growing global pet population and the need for disease prevention in farm animals, is leading to more collaborations between pharmaceutical companies and CDMOs. By outsourcing manufacturing operations, veterinary companies can focus on core areas like R&D and marketing, reducing overall operational costs while ensuring timely production and distribution of high-quality veterinary products.
The "Medicines" subsegment within the veterinary CRO and CDMO market encompasses the development, production, and testing of pharmaceutical products designed to treat a wide range of animal conditions. These medicines can include antibiotics, vaccines, pain management drugs, anti-inflammatory agents, and other therapeutic solutions aimed at improving animal health. Veterinary CROs play a pivotal role in supporting the drug discovery process through preclinical studies, clinical trials, and regulatory affairs, ensuring that new medicines meet safety and efficacy standards. Meanwhile, veterinary CDMOs provide the necessary manufacturing services to produce these medicines at scale, ensuring compliance with Good Manufacturing Practices (GMP) while meeting demand for high-quality products. The growing prevalence of animal diseases and the rising focus on animal welfare are expected to drive demand for innovative veterinary medicines, propelling growth in this subsegment.
Furthermore, the global trend toward personalized veterinary medicine, where treatments are tailored to individual animals' needs, is gaining momentum in this subsegment. Veterinary CROs and CDMOs are at the forefront of this trend, offering the flexibility and expertise needed to bring such individualized treatments to market. This subsegment is also benefiting from the increased demand for companion animal care products, as pet owners become more invested in the health and well-being of their pets. As more innovative and effective medicines are developed for both companion and farm animals, the role of veterinary CROs and CDMOs will continue to grow, with these organizations providing essential services in the development, testing, and manufacturing of new veterinary medicines.
The "Medical Devices" subsegment in the veterinary CRO and CDMO market involves the development and production of devices used in the diagnosis, treatment, and management of various animal health conditions. These devices can range from diagnostic tools, such as imaging systems and laboratory equipment, to surgical instruments and implantable devices used for procedures like joint replacement or pacemaker insertion. Veterinary CROs contribute to this subsegment by providing support for clinical trials, safety testing, and regulatory approval processes required for medical devices. In addition, they assist with the design and development of new devices that cater specifically to veterinary needs. The increasing demand for advanced veterinary medical devices is driven by the growing sophistication of animal health practices, as well as the need for more precise and effective treatment options.
Veterinary CDMOs support the medical devices subsegment by manufacturing these devices in compliance with regulatory standards. Their role extends beyond simple production, encompassing design, testing, validation, and packaging to ensure that medical devices are safe and reliable for use in animal healthcare settings. With the rapid advancements in technology and the increasing prevalence of complex medical conditions in animals, veterinary CDMOs are essential in bringing new medical devices to market. As pet owners and veterinary professionals continue to demand higher-quality medical care for animals, the medical devices subsegment will continue to experience growth, driven by the need for better diagnostics, therapeutic tools, and surgical solutions.
The veterinary CRO and CDMO market is expected to continue its upward trajectory due to several key trends and emerging opportunities. One of the most notable trends is the increasing outsourcing of R&D and manufacturing activities by pharmaceutical and biotechnology companies. By partnering with CROs and CDMOs, companies can reduce their overhead costs, streamline operations, and gain access to specialized expertise in regulatory compliance, clinical trials, and manufacturing. This trend is particularly prevalent in the veterinary space, as companies seek to leverage external partners' capabilities in developing and producing animal health products quickly and efficiently.
Another significant trend is the rise in demand for personalized veterinary medicine. With advancements in genomics and biotechnology, veterinary treatments are becoming more tailored to the specific needs of individual animals. This has led to greater opportunities for CROs and CDMOs to play a crucial role in developing, testing, and manufacturing personalized veterinary medicines. As animal health continues to be a focus for pet owners and farmers alike, there is a growing demand for more effective treatments for both companion animals and livestock. This trend presents opportunities for veterinary CROs and CDMOs to expand their services and offer innovative solutions that cater to the evolving needs of the veterinary market.
Furthermore, the increasing global pet population, especially in emerging markets, presents a significant growth opportunity for the veterinary CRO and CDMO market. As more people in these regions adopt pets and invest in their healthcare, there will be a rising demand for quality veterinary medicines and medical devices. Additionally, the ongoing advancements in veterinary diagnostics, such as imaging and laboratory testing technologies, are expected to create new opportunities for veterinary CROs and CDMOs to support innovation and development in the veterinary field. This growth in the pet industry, coupled with the rising awareness of animal health, presents a strong market opportunity for the key players in the veterinary CRO and CDMO space.
1. What is the role of a Veterinary CRO?
A Veterinary CRO provides research and clinical trial services to veterinary pharmaceutical companies, accelerating the development of new veterinary drugs and treatments.
2. What services do Veterinary CDMOs provide?
Veterinary CDMOs offer manufacturing services for veterinary medicines and medical devices, handling production, formulation, packaging, and regulatory compliance.
3. How are Veterinary CROs supporting innovation in animal health?
Veterinary CROs assist with R&D, clinical trials, data management, and regulatory approvals to bring innovative products to market faster and more effectively.
4. What are the key factors driving the growth of the Veterinary CRO and CDMO market?
Key drivers include the increasing outsourcing of R&D and manufacturing services, growing demand for personalized veterinary medicine, and the rise in global pet ownership.
5. Why is there a growing demand for Veterinary CDMOs?
The demand for Veterinary CDMOs is driven by the need for high-quality, scalable manufacturing solutions for veterinary medicines and medical devices to meet market needs.
6. What are the main applications of veterinary medical devices?
Veterinary medical devices are used for diagnostics, surgical procedures, and monitoring health conditions in animals, ranging from imaging tools to implantable devices.
7. How do Veterinary CDMOs help in regulatory compliance?
Veterinary CDMOs ensure that the manufacturing processes for veterinary products meet regulatory standards, including safety, efficacy, and quality assurance measures.
8. What is driving the increasing popularity of personalized veterinary medicine?
Advances in genomics and biotechnology are enabling more targeted, individualized treatments for animals, responding to the unique needs of each animal.
9. How is the global pet population influencing the veterinary market?
The growing number of pets worldwide is driving demand for veterinary products and services, contributing to the expansion of the veterinary CRO and CDMO market.
10. What are the benefits of outsourcing to Veterinary CROs and CDMOs?
Outsourcing to Veterinary CROs and CDMOs helps companies reduce costs, access specialized expertise, and speed up product development and market entry.
For More Information or Query, Visit @ Veterinary CRO and CDMO Market Size And Forecast 2025-2030